Thermo Scientific 365JLT41 500uL Syringe HPLC Autosampler LCQ Simple Injection
Unused and never put into service. It may be an older model and may not come in its original packaging. Minor marks from storage are possible.
Thermo Scientific
Questions about this item? Call us (760) 560-0013
Details
-
CategoryHPLC / FPLC / GC / CE
-
Dimension18.0cm x 3.0cm x 8.0cm
-
Shipping TypeFedEx Ground
Description
The Thermo Scientific 365JLT41 500uL Syringe is designed for precise and reproducible injections in HPLC systems. This new 500 microliter RN GT LC syringe features a square tip to prevent injector damage and offers a wide range of volumes. Constructed with high-quality borosilicate glass and stainless steel, the syringe provides durability and easy-to-read markings. Compatible with LCQ HPLC equipment, it features a removable needle of 2 inches (50 mm) in length, a 22 gauge needle, and a volume capacity of 500 µL. As a new device, it may exhibit minor cosmetic imperfections but is unused and in excellent condition for reliable laboratory applications.
Key Features
- 500 uL capacity
- Square tip design
- Made from borosilicate glass
- Stainless steel construction
- Removable 2-inch needle
- For use with LCQ HPLC equipment
- Easy-to-read markings
Specifications
- Volume: 500 µL
- Needle Length: 2 in / 50 mm
- Needle Gauge: 22G
- Disposable/Re-usable: Dis/Re
- Material: Borosilicate Glass and Stainless Steel
Weight
Imperial: 0.26 Pounds
Metric: 0.12 Kilograms
Shipping Dimensions
Imperial: 8.4 lb x 1.2 lb x 3.6 lb
Metric: 21.34 cm x 3.05 cm x 9.14 cm
Harmonized Code
9027.80.45
Harmonized Code Details
9027.80.45 - Instruments and apparatus for physical or chemical analysis: Liquid chromatography apparatus for particular uses. This code applies to precision instruments used in chemical analysis.
Product Enquiry
Have a question about this product? Send us your enquiry and our sales team will get back to you shortly.
Inform me when available
This item has sold. Leave your details and we will get in touch when a similar model becomes available.
Comments 0
There are currently no public comments.